FindTrial
Sign In

Innovative oncoplastic techniques for breast cancer patients with small to medium volume breast

Innovative oncoplastic techniques for breast cancer patients with small to medium volume breast

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051636
Enrollment
Unknown
Registered
2021-09-28
Start date
2017-09-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breastcancer

Interventions

Group 1:oncoplastic
Group 1:traditional breast conserving surgery

Sponsors

Guilin TCM Hospital of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 64 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion are confirmed diagnosis of invasive Breast cancer stages I to II who underwent primary traditional breast conserving surgery (TBCS) or breast conservative oncoplastic surgery (BCOS) after tumor removal, in the Guilin Hospital of China between 2017 to 2021.

Exclusion criteria

Exclusion criteria: Cases with other stages of disease or different treatments as well as patients treated outside of the proposed time-range were excluded.

Design outcomes

Primary

MeasureTime frame
tumor satety;—

Secondary

MeasureTime frame
aesthetic results;—

Countries

China

Contacts

Public ContactRui Zhuo

Guilin TCM Hospital Of China

merstudio@sina.com+86 18978698257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026